Applications Predicts patient response to NADT in prostate cancer treatment. Identifies patients likely to benefit from mTOR inhibitors. Enables personalized treatment strategies for improved outcomes. Advantages/Benefits Faster and cheaper biomarker identification process than traditional methods High predictive accuracy for treatment outcomes and … [Read more...] about 2025-013 AI-Powered Cellular Morphometric Biomarkers for Classification of Prostate Cancer for Neoadjuvant Androgen Deprivation Therapy (NADT)
CS Biotechnology
2024-126 AI-empowered Cellular Morphometric Biomarkers in Kidney Cancer patients to predict treatment response and prognosis
Applications Classifies clear cell renal cell carcinoma (ccRCC) patients to predict treatment response and prognosis. Personalized therapy selection, including immunotherapy and mTOR inhibitors. Advantages/Benefits Faster and cheaper biomarker identification process than traditional methods High predictive accuracy for treatment outcomes and prognosis … [Read more...] about 2024-126 AI-empowered Cellular Morphometric Biomarkers in Kidney Cancer patients to predict treatment response and prognosis
Discovery of Robust Cellular Morphometric Subtypes in Lower Grade Glioma through Machine Learning 2021-064
APPLICATIONS OF TECHNOLOGY: Identifying clinically significant subtypes for different tumors BENEFITS: Provides new knowledge that improves diagnosis and optimization of treatment Cost-effective compared with hematoxylin and eosin (H&E) stained histology sections Promises significant clinical value combined with well-known factors (i.e., clinical factors … [Read more...] about Discovery of Robust Cellular Morphometric Subtypes in Lower Grade Glioma through Machine Learning 2021-064